Search
Biomea’s Icovamenib Drug Shows Potential for Diabetes Patients
Biomea’s icovamenib shows lasting blood sugar reduction in type 2 diabetes, offering new hope for patients unresponsive to GLP-1 treatments.
Rylee Arnold Shares Journey Managing Diabetes on DWTS
Rylee Arnold reveals how she manages Type 1 diabetes on DWTS—balancing her Dexcom device, diet, and performance demands with honesty…
Managing Stress to Combat Diabetes Risk
Research reveals how stress triggers higher blood sugar through brain-liver signals — and simple lifestyle changes can help prevent Type…
Transform Your Health: Three Simple Steps to Prevent Diabetes
The PREDIMED-Plus study shows that diet, exercise, and guidance can cut your risk of diabetes by 31%. Here’s how to…
Novo Nordisk Resubmits Awiqli Application to FDA
Novo Nordisk resubmits Awiqli for FDA review, aiming to revolutionize type 2 diabetes treatment with once-weekly insulin dosing.